PRTK
Paratek Pharmaceuticals, Inc.
PRTK
PRTK
Delisted
PRTK was delisted on the 20th of September, 2023.
76 hedge funds and large institutions have $68.8M invested in Paratek Pharmaceuticals, Inc. in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 29 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
34% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 29
Holders
76
Holding in Top 10
1
Calls
$108K
Puts
$17K
Top Buyers
| 1 | +$26.3M | |
| 2 | +$513K | |
| 3 | +$504K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$419K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$302K |
Top Sellers
| 1 | -$1.29M | |
| 2 | -$764K | |
| 3 | -$531K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$448K |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$155K |